Trials / Sponsors / Guangzhou Ruixin Biotechnological Co., LTD
Guangzhou Ruixin Biotechnological Co., LTD
Industry · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer Small Cell Lung Cancer | EARLY_Phase 1 | 2024-12-15 |
| Not Yet Recruiting | Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenou Acute Myeloid Leukemia (AML) | EARLY_Phase 1 | 2024-11-25 |